Submitted by Anonymous (not verified) on 27 January 2026 - 13:35
Human medicines European public assessment report (EPAR): Avastin, bevacizumab, Date of authorisation: 12/01/2005, Revision: 68, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Avastin, bevacizumab, Date of authorisation: 12/01/2005, Revision: 68, Status: Authorised